InventorsAssigneeUS Classes435/5, Involving virus or bacteriophage435/69.1, Recombinant DNA technique included in method of making a protein or polypeptide435/456, The polynucleotide is encapsidated within a virus or viral coat435/366, Human536/23.72, Viral protein530/350PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUESAttorney, Agent or FirmInternational ClassesC12Q 1/70C07H 21/04 C12P 21/06 C07K 14/005 C12N 15/86 Issued Patent Number:7527961Abstract textMeans and methods for producing mammalian viruses, the method comprising infecting a culture of immortalized human cells with a virus, incubating the culture infected with virus to propagate the virus under conditions that permit growth of the virus, and to form a virus-containing medium, and removing the virus-containing medium. The viruses can be harvested and be used for the production of vaccines. Advantages include that human cells of the present invention can be cultured under defined serum-free conditions and the cells show improved capability for propagating virus. Methods are provided for producing, in cultured human cells, influenza virus and vaccines derived thereof. This method eliminates the necessity of using whole chicken embryos for the production of Influenza vaccines. The method also provides for the continuous or batch-wise removal of culture media. As such, the present invention allows the large-scale continuous production of viruses to a high titer. |
| ||||||||||||||